• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在表达突变型亨廷顿蛋白N端片段的转基因小鼠中的核内包涵体和神经突聚集体。

Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.

作者信息

Schilling G, Becher M W, Sharp A H, Jinnah H A, Duan K, Kotzuk J A, Slunt H H, Ratovitski T, Cooper J K, Jenkins N A, Copeland N G, Price D L, Ross C A, Borchelt D R

机构信息

Department of Psychiatry, Division of Neuropathology, Johns Hopkins University, Baltimore, MD 21205-2196, USA.

出版信息

Hum Mol Genet. 1999 Mar;8(3):397-407. doi: 10.1093/hmg/8.3.397.

DOI:10.1093/hmg/8.3.397
PMID:9949199
Abstract

Huntington's disease (HD) is an inherited, neurodegenerative disorder caused by the expansion of a glutamine repeat in the N-terminus of the huntingtin protein. To gain insight into the pathogenesis of HD, we generated transgenic mice that express a cDNA encoding an N-terminal fragment (171 amino acids) of huntingtin with 82, 44 or 18 glutamines. Mice expressing relatively low steady-state levels of N171 huntingtin with 82 glutamine repeats (N171-82Q) develop behavioral abnormalities, including loss of coordination, tremors, hypokinesis and abnormal gait, before dying prematurely. In mice exhibiting these abnormalities, diffuse nuclear labeling, intranuclear inclusions and neuritic aggregates, all immunoreactive with an antibody to the N-terminus (amino acids 1-17) of huntingtin (AP194), were found in multiple populations of neurons. None of these behavioral or pathological phenotypes were seen in mice expressing N171-18Q. These findings are consistent with the idea that N-terminal fragments of huntingtin with a repeat expansion are toxic to neurons, and that N-terminal fragments are prone to form both intranuclear inclusions and neuritic aggregates.

摘要

亨廷顿舞蹈病(HD)是一种遗传性神经退行性疾病,由亨廷顿蛋白N端谷氨酰胺重复序列的扩增引起。为深入了解HD的发病机制,我们构建了转基因小鼠,这些小鼠表达编码亨廷顿蛋白N端片段(171个氨基酸)的cDNA,该片段含有82、44或18个谷氨酰胺。表达相对低稳态水平且含有82个谷氨酰胺重复序列的N171亨廷顿蛋白(N171-82Q)的小鼠,在过早死亡前会出现行为异常,包括协调能力丧失、震颤、运动功能减退和步态异常。在表现出这些异常的小鼠中,在多个神经元群体中发现了弥漫性核标记、核内包涵体和神经突聚集物;用针对亨廷顿蛋白N端(氨基酸1-17)的抗体(AP194)检测,这些结构均呈免疫反应性。在表达N171-18Q的小鼠中未观察到这些行为或病理表型。这些发现与以下观点一致:具有重复序列扩增的亨廷顿蛋白N端片段对神经元有毒性,且N端片段易于形成核内包涵体和神经突聚集物。

相似文献

1
Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.在表达突变型亨廷顿蛋白N端片段的转基因小鼠中的核内包涵体和神经突聚集体。
Hum Mol Genet. 1999 Mar;8(3):397-407. doi: 10.1093/hmg/8.3.397.
2
Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice.突变亨廷顿蛋白片段的核靶向在转基因小鼠中产生亨廷顿舞蹈病样表型。
Hum Mol Genet. 2004 Aug 1;13(15):1599-610. doi: 10.1093/hmg/ddh175. Epub 2004 Jun 9.
3
Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.谷氨酰胺重复序列扩增的亨廷顿蛋白截短型N端片段在细胞培养中形成核内和胞质聚集体。
Hum Mol Genet. 1998 May;7(5):783-90. doi: 10.1093/hmg/7.5.783.
4
Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.在可诱导全长突变型亨廷顿蛋白表达的转基因小鼠模型中,氨基末端裂解片段的进行性表型和核内积累。
Neurobiol Dis. 2006 Feb;21(2):381-91. doi: 10.1016/j.nbd.2005.07.014. Epub 2005 Sep 16.
5
Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease.突变亨廷顿蛋白在患有亨廷顿舞蹈症的小鼠中引发情境依赖性神经退行性变。
J Neurosci. 2003 Mar 15;23(6):2193-202. doi: 10.1523/JNEUROSCI.23-06-02193.2003.
6
Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.亨廷顿舞蹈病、齿状核红核苍白球路易体萎缩症中的核内神经元包涵体:包涵体密度与IT15 CAG三联体重复长度之间的相关性
Neurobiol Dis. 1998 Apr;4(6):387-97. doi: 10.1006/nbdi.1998.0168.
7
Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative.表达突变 huntingtin 衍生的 caspase-6 N 端片段的转基因小鼠表现出神经异常,主要由较小的蛋白水解衍生物组成的细胞质包涵体病理学为主。
Hum Mol Genet. 2011 Jul 15;20(14):2770-82. doi: 10.1093/hmg/ddr176. Epub 2011 Apr 22.
8
Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice.亨廷顿蛋白聚集体相关的轴突退变是亨廷顿病小鼠的早期病理事件。
J Neurosci. 2001 Nov 1;21(21):8473-81. doi: 10.1523/JNEUROSCI.21-21-08473.2001.
9
Experimental mutagenesis of huntingtin to map cleavage sites: different outcomes in cell and mouse models.对亨廷顿蛋白进行实验性诱变以确定切割位点:细胞和小鼠模型中的不同结果
J Huntingtons Dis. 2014;3(1):73-86. doi: 10.3233/JHD-130087.
10
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.表达突变全长亨廷顿舞蹈病(HD)互补DNA的转基因小鼠:亨廷顿舞蹈病运动变化和选择性神经元丢失的范例
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456.

引用本文的文献

1
Huntingtin preserves mitochondrial genome integrity in neurons, which is impaired in Huntington's disease.亨廷顿蛋白可维持神经元中线粒体基因组的完整性,而在亨廷顿舞蹈症中这种完整性会受到损害。
bioRxiv. 2025 Jul 24:2025.07.24.666629. doi: 10.1101/2025.07.24.666629.
2
Nanozymes: Innovative Therapeutics in the Battle Against Neurodegenerative Diseases.纳米酶:对抗神经退行性疾病的创新疗法
Int J Mol Sci. 2025 Apr 9;26(8):3522. doi: 10.3390/ijms26083522.
3
Lipidomics of Huntington's Disease: A Comprehensive Review of Current Status and Future Directions.
亨廷顿病的脂质组学:现状与未来方向的全面综述
Metabolites. 2025 Jan 2;15(1):10. doi: 10.3390/metabo15010010.
4
Increased nuclear import characterizes aberrant nucleocytoplasmic transport in neurons from patients with spinocerebellar ataxia type 7.核输入增加是7型脊髓小脑共济失调患者神经元中异常核质转运的特征。
Front Mol Neurosci. 2024 Nov 22;17:1478110. doi: 10.3389/fnmol.2024.1478110. eCollection 2024.
5
Dysregulation of zebrin-II cell subtypes in the cerebellum is a shared feature across polyglutamine ataxia mouse models and patients.小脑中 zebrin-II 细胞亚型的失调是多聚谷氨酰胺相关共济失调小鼠模型和患者的共同特征。
Sci Transl Med. 2024 Nov 6;16(772):eadn5449. doi: 10.1126/scitranslmed.adn5449.
6
Luteolin as potential treatment for Huntington's disease: Insights from a transgenic mouse model.木犀草素作为亨廷顿病治疗的潜在药物:来自转基因小鼠模型的见解。
CNS Neurosci Ther. 2024 Sep;30(9):e70025. doi: 10.1111/cns.70025.
7
Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington's disease models.靶向外显子1的微小RNA在亨廷顿舞蹈病模型中可减少致病性外显子1亨廷顿蛋白。
Brain. 2024 Dec 3;147(12):4043-4055. doi: 10.1093/brain/awae266.
8
Large animal models for Huntington's disease research.用于亨廷顿病研究的大动物模型。
Zool Res. 2024 Mar 18;45(2):275-283. doi: 10.24272/j.issn.2095-8137.2023.199.
9
The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease.临床前磁共振成像和光谱学对亨廷顿舞蹈病的贡献。
Front Aging Neurosci. 2024 Feb 13;16:1306312. doi: 10.3389/fnagi.2024.1306312. eCollection 2024.
10
Fluorescent protein tagging promotes phase separation and alters the aggregation pathway of huntingtin exon-1.荧光蛋白标记促进相分离,并改变亨廷顿外显子 1 的聚集途径。
J Biol Chem. 2024 Jan;300(1):105585. doi: 10.1016/j.jbc.2023.105585. Epub 2023 Dec 21.